Therefore, DJ-1 can be used as a potential biomarker for diagnosing general anesthetic-induced neurotoxicity and as a therapeutic target for the prevention and intervention of general anesthetic neurotoxicity and cognitive impairment in the developing brain. This evidence concerns the gene PARK7 and Cognitive impairment.